The consistent results between bioinformatics and biological investigation suggested convincing evidence that hub genes including GABARAPL1, SGTA, ARRB1, GPX8, and VCAM1 were abnormally expressed in IPF and could be utilized as a promising novel target for IPF treatment. The gene discussed is GABARAPL1; the disease is idiopathic pulmonary fibrosis.